Formed in early 2021, the National Patient Safety Board (NPSB)1 — modeled intentionally on the US National Transportation Safety Board — seeks to reduce medical errors by adopting risk and safety measures developed by airlines.2 Having successfully persuaded pilots, controllers and mechanics to voluntarily report hazards, accidents and near-misses, airlines have used such incident data to draw safety lessons and disseminate those among one another. This coordinated industry exercise in risk management has significantly reduced the number of crashes and other safety management failures. Hospitals now look to do likewise. “The NPSB would support agencies in monitoring and anticipating adverse events with artificial intelligence,” it proposes. It also aspires to, “conduct studies, create recommendations and solutions to prevent medical error, and leverage existing systems and bring key learnings into practice.”3
Cross-industry collaboration4 and public-private partnerships5 have been central to the success of covid-vaccine development. AI is now enabling scientists to predict how viruses will evolve, positioning them to develop vaccines in advance of an outbreak, and to prime human immune systems to resist pathogens to which they have yet to be exposed.6
This content is available to both premium Members and those who register for a free Observer account.
If you are a Member or an Observer of Starling Insights, please sign in below to access this article.
Members enjoy full access to all articles and related content from past editions of the Compendium as well as Starling's special reports. Observers can access a limited number of articles and may purchase articles on an ala carte basis.
You can click the 'Join' button below to become a Member or to register for free as an Observer.
Join The Discussion